InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Drapkin Kimberlee C, Chief Financial Officer. Director active across 2 companies, notably Jounce Therapeutics, Inc.. Aggregated, 7 filings have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €66k. Activity tracked since 7 January 2022. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations7 total
35,500 shares0Common StockSEC:0001628280-26-041276:0
25,751 sharesCommon StockSEC:0001640455-23-000107:0
6,315 shares@ US$1.109.9% of flowCommon StockSEC:0001640455-23-000009:0
27,500 shares0Common StockSEC:0001640455-22-000018:0
27,500 shares0Common StockSEC:0001640455-22-000018
4,595 shares@ US$7.3045.1% of flowCommon StockSEC:0001640455-22-000009
4,595 shares@ US$7.3050.0% of flowCommon StockSEC:0001640455-22-000009:0
7 of 7 declarations
About Drapkin Kimberlee C
Kimberlee C. Drapkin is the CFO and Treasurer at Jounce Therapeutics, Inc. She oversees the financial functions of the company, ensuring compliance and effective management of financial resources. Her expertise is essential for strategic planning and decision-making.
